4//SEC Filing
MABVAX THERAPEUTICS HOLDINGS, INC. 4
Accession 0001415889-17-000021
CIK 0001109196operating
Filed
Jan 2, 7:00 PM ET
Accepted
Jan 3, 8:55 PM ET
Size
5.4 KB
Accession
0001415889-17-000021
Insider Transaction Report
Form 4
Cohen Kenneth M
Director
Transactions
- Award
Option to Purchase Common Stock
2017-01-01$3.38/sh+4,100$13,858→ 4,100 totalExercise: $3.38Exp: 2027-01-01→ Common Stock (4,100 underlying)
Footnotes (1)
- [F1]Such Options shall vest in equal annual installments over a three year period.
Documents
Issuer
MABVAX THERAPEUTICS HOLDINGS, INC.
CIK 0001109196
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001109196
Filing Metadata
- Form type
- 4
- Filed
- Jan 2, 7:00 PM ET
- Accepted
- Jan 3, 8:55 PM ET
- Size
- 5.4 KB